Program Information
Radiobiological Evaluation of Intensity Modulated Radiotherapy Treatment for Locally Advanced Head and Neck Squamous Cell Carcinomas
R BUCHAPUDI1*, R MANICKAM1 , C TANVIRPASHA1 , M ANIL KUMAR1 , A Pyakuryal2 , V Chandraraj1 , G Narayanasamy3 , (1) KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY, Bangalroe, KARNATAKA, (2) National Cancer Institute, Bethesda, MD, (3) CME. DEPT./UTHSCSA, San Antonio, TX
Presentations
SU-E-T-275 Sunday 3:00PM - 6:00PM Room: Exhibit HallPurpose:
To evaluate the radiobiological outcome of Intensity Modulated Radiotherapy Treatment (IMRT) for locally advanced head and neck squamous cell carcinomas using HART (Histogram Analysis in Radiation Therapy; J Appl Clin Med Phys 11(1): 137-157, 2010) program and compare with the clinical outcomes.
Methods:
We have treated 20 patients of stage III and IV HNSCC Oropharynx and hypopharynx with accelerated IMRT technique and concurrent chemotherapy. Delineation of tumor and normal tissues were done using Danish Head and Neck Cancer Group (DAHANCA) contouring guidelines and radiotherapy was delivered to a dose of 70Gy in 35 fractions to the primary and involved lymph nodes, 63Gy to intermediate risk areas and 56 Gy to lower risk areas, Monday to Saturday, 6 Days/week using 6 MV Photons with an expected overall treatment time of 6 weeks. The TCP and NTCP's were calculated from the dose-volume histogram (DVH) statistics using the Poisson Statistics (PS) and JT Lyman models respectively and the result was correlated with clinical outcomes of the patients with mean follow up of 24 months.
Results:
Using HART program, the TCP (0.89± 0.01) of primary tumor and the NTCP for parotids (0.20±0.12), spinal cord (0.05±0.01), esophagus (0.30±0.2), mandible (0.35±0.21), Oral cavity (0.37±0.18), Larynx (0.30±0.15) were estimated and correlated with clinical outcome of the patients.
Conclusion:
Accelerated IMRT with Chemotherapy is a clinical feasible option in the treatment of locally advanced HNSCC with encouraging initial tumour response and acceptable acute toxicities. The correlation between the clinical outcomes and radiobiological model estimated parameters using HART programs are found to be satisfactory.
Contact Email: